มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - pazopanib - film tableta - 400mg

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - pazopanib - film tableta - 200mg

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

zentiva pharma doo - dio stranog druŠtva podgorica - pazopanib - film tableta - 400mg

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

rhei life doo beograd - dio stranog druŠtva podgorica - pazopanib - film tableta - 200mg

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

rhei life doo beograd - dio stranog druŠtva podgorica - pazopanib - film tableta - 400mg

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

zentiva pharma doo - dio stranog druŠtva podgorica - pazopanib - film tableta - 200mg

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - cjepivo protiv pandemijskog gripa (h5n1) (split Вирион, инактивированный, адъювантом) - influenza, human; immunization; disease outbreaks - cjepiva - profilakcija gripe u službeno prijavljenoj pandemijskoj situaciji. pandemije gripe cjepivo bi trebao biti korišten u skladu sa službenim vodstvom.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - hepatitis b; hepatitis a; immunization - cjepiva - ambirix se upotrebljava u ne-imunim osobama od jedne godine do uključivo 15 godina za zaštitu od hepatitisa a i infekcije hepatitisa-b. zaštita od infekcije hepatitisa b ne mogu se dobiti samo nakon druge doze. stoga:ambirix treba koristiti samo onda kada postoji relativno nizak rizik tijekom tečaja cijepljenje za hepatitis b infekcije, preporučuje se ambirix treba propisati na mjestima gdje završetka doze tečaj cijepljenje mogu biti sigurni.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - bromid umeclidinium, vilanterol trifenatate - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - anoro ellipta navodi kao terapiju održavanja бронходилататор za ublažavanje simptoma kod odraslih bolesnika s kroničnom opstruktivnom plućnom bolesti (kopb).